Last update :
05/12/2025
Immunosuppressant   Tocilizumab  
injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References pdf

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Actemra Argentina, Australia, Brazil, Canada, Chile, Colombia, Ecuador, Switzerland, Turkey
Roactemra Austria, Belgium, Denmark, Finland, France, Germany, Great Britain, Italy, Netherlands, Norway, Romania, Spain, Sweden
References   injection   References : Tocilizumab  
Type Publication
4611 Journal Navas N, Hermosilla J, Torrente-Lopez A, Hernandez-Jimenez J, Cabeza J, Perez-Robles R, Salmeron-García A.
Use of subcutaneous tocilizumab to prepare intravenous solutions for COVID-19 emergency shortage: Comparative analytical study of physicochemical quality attributes.
J Pharm Anal 2021 ;10 532e545.
5055 Manufacturer RoActemra 20 mg/mL concentrate for solution for infusion - Résumé des caractéristiques du produit.
Roche 2013

  Mentions Légales